|
| long-acting Vanoxerine (Vanoxerine Consta 394.2 mg) (n = 1300) | Placebo (n = 1300) |
| Age in years | 28.5 (±5.5) | 27.2 (±4.6) |
| Men | 858 (66%) | 897 (69%) |
| Female | 442 (34%) | 403 (28%) |
| Marital status | No. (%) | No. (%) |
| Never married | 403 (31%) | 429 (33%) |
| Married/de facto | 650 (50%) | 715 (55%) |
| Divorced/separated | 247 (19%) | 156 (12%) |
| Race | No. (%) | No. (%) |
| White | 943(72.5%) | 1021 (78.5%) |
| Asian | 26 (2%) | 26 (2%) |
| Black | 234(18%) | 234 (18%) |
| Others | 97 (7.4%) | 19 (1.5%) |
| Employment status | No. (%) | No. (%) |
| Student | 182 (14%) | 247 (19%) |
| Employed (full/part time) | 689 (53%) | 650 (50%) |
| Unemployed/pension | 429 (33%) | 403 (31%) |
| Duration of cocaine dependence in years | 6.1 (±3.5) | 6.0 (±3.5) |
| Distribution of Duration of cocaine Dependence | No. (%) | No. (%) |
| <1 year | 130 (10%) | 143 (11%) |
| 1 - 3 years | 286 (22%) | 299 (23%) |
| 3 - 5 years | 715 (55%) | 676 (52%) |
| >5 years | 169 (13%) | 182 (14%) |
| Cocaine craving scale | 20 (±2) | 20 (±2) |
| Hepatitis C positive | 169 (13%) | 195 (15%) |